Late fulminant posterior reversible encephalopathy syndrome after liver transplant

Experimental and Clinical Transplantation

Volumn 7, Issue 3, 2009, Pages 180-183

  Heidenhain, Christoph ^a   Puhl, Gero ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adverse event; Calcineurin inhibitor; Immunosuppression; Neurotoxicity; Tacrolimus

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE REPORT; COMA; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; GRAY MATTER; HEADACHE; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; TREATMENT WITHDRAWAL; TREMOR;

CALCINEURIN; COMA; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYCOPHENOLIC ACID; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PREDNISOLONE; TACROLIMUS; TIME FACTORS;

EID: 75149192844     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69(4):467-472.
2. Kilinc M, Benli S, Can U, et al. FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. Transplant Proc. 2002 Jun;34(4):1182-1184.
3. Fung JJ, Alessiani M, Abu-Elmagd K, et al. Adverse effects associated with the use of FK 506. Transplant Proc. 1991;23(6):3105-3108.
4. Mueller AR, Platz KP, Schattenfroh N, Bechstein WO, Christe W, Neuhaus P. Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patients. Transpl Int. 1994;7(suppl 1):S37-S42.
5. Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol. 2001;16(7):537-542.
6. Kaczmarek I, Groetzner J, Meiser B, et al. Impairment of the blood-brain barrier can result in tacrolimus-induced reversible leucoencephalopathy following heart transplantation. Clin Transplant. 2003;17(5):469-472.
7. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998;66(12):1596-1604.
8. Schuuring J, Wesseling P, Verrips A. Severe tacrolimus leukoencephalopathy after liver transplantation. AJNR Am J Neuroradiol. 2003;24(10):2085-2088.
9. Wong R, Beguelin GZ, de Lima M, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2003;122(1):128-134.